Table 3.
Beliefs about medicines questionnaire (ref) outcomes including scores for concern, necessity, necessity–concern differential, harm and overuse by patient medications, complementary therapy usage, medication adherence scores, active disease, and medication change due to coronavirus disease 2019 pandemic
| Concern scoreMean, 95% CI | Necessity scoreMedian, IQR | Necessity–concern differentialMean, 95% CI | Harm scoreMean, 95% CI | Overuse scoreMean, 95% CI | |
|---|---|---|---|---|---|
| Biologic therapy use (n = 148) | 14.4 (1.7–15.1) P = 0.53 | 21 (19–24)P < 0.001 | 6.7 (5.9–7.6) P = 0.0038 | 8.3 (7.8–8.8) P = 0.32 | 9.3 (8.7–9.7) P = 0.003 |
| Immunomodulator use (n = 99) | 14.3 (13.5–15.1) P = 0.84 | 20 (19–23)P = 0.37 | 6.1 (5.0–7.3) P = 0.61 | 8.4 (7.85–9.0) P = 0.85 | 9.6 (8.9–10.3) P = 0.73 |
| 5ASA therapy use (n = 68) | 13.7 (12.4–14.9) P = 0.20 | 20 (16–23) P = 0.017 | 5.5 (4.0–7.0) P = 0.47 | 8.1 (7.5–8.7) P = 0.28 | 9.7 (9.0–10.4) P = 0.99 |
| Prednisolone usage (n = 11) | 17 (13.4–20.6) P = 0.02 | 21.5 (20–23)P = 0.28 | 4.4 (0.6–8.1) P = 0.37 | 10.3 (7.4–13.2) P = 0.03 | 10.8 (8.4–13.2)P = 0.26 |
| Frequent complementary therapy usage (n = 89) | 15.1 (14.2–16.1) P = 0.021 | 20 (18–23)P = 0.56 | 4.9 (3.6–6.2) P = 0.04 | 9 (8.2–9.7) P = 0.03 | 10.2 (9.4–10.1) P = 0.09 |
| Adherent medication adherence scores(n = 178) | 13.7 (13.1–14.3) P = 0.0005 | 21(19–24)P = 0.0011 | 6.9 (6.2–7.7) P < 0.0001 | 8.3 (7.9–8.7) P = 0.15 | 9.3 (8.9–9.8) P = 0.005 |
| Active disease(n = 60) | 16.1 (15.1–17.1) P = 0.0001 | 20 (18–23)P = 0.80 | 4.2 (2.7–5.7) P = 0.007 | 9.3 (8.5–10.1) P = 0.007 | 10.3 (9.4–11.1) P = 0.12 |
| Medication change due to COVID‐19 (n = 14) | 16.6 (13.8–19.4) P = 0.04 | 21(19–22)P = 0.99 | 3.8 (0.62–6.9)P = 0.15 | 9.25 (7.0–11.5)P = 0.31 | 10.4 (8.2–12.7)P = 0.37 |
Necessity–concern differential calculated by taking concern score away from necessity score. Mean and 95% confidence interval (CI) or median and interquartile range (IQR) as appropriate. Comparisons to remaining population using Student's t‐test or Wilcoxon rank‐sum test when appropriate. Median necessity score was 20 (IQR 18–23), with mean Concern score of 14.3 (SD 4.2), mean Harm score was 8.4 (SD 2.8), and mean Overuse score was 9.7 (SD 3.1).